Mikhail Binnewies
- Immunology top 0.2%
- Immune cells in cancer 10
- Immunotherapy and Immune Responses 7
- Inflammation biomarkers and pathways 4
- Immune Cell Function and Interaction 3
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 3
- Hematology top 1%
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 3
- Cancer Research top 2%
- Genetics top 2%
- Co-authors
- Matthew F. KrummelEdward W. RobertsKelly KerstenVincent ChanDmitry I. GabrilovichWeiping ZouSuzanne Ostrand‐RosenbergLisa M. Coussens
- Cited by
- ImmunologyOncologyHematology
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Mikhail Binnewies
19 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Immunology 4.5k
- Oncology 3.9k
- Hematology 908
- Cancer Research 1.0k
- Genetics 490
Countries citing papers authored by Mikhail Binnewies
This map shows the geographic impact of Mikhail Binnewies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail Binnewies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail Binnewies more than expected).
Fields of papers citing papers by Mikhail Binnewies
This network shows the impact of papers produced by Mikhail Binnewies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail Binnewies. The network helps show where Mikhail Binnewies may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mikhail Binnewies, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 1 | |
| 4 | 2021 | 2 | |
| 5 | 2020 | 160 | |
| 6 | 2019 | 91 | |
| 7 | Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunitybreakdown → | 2019 | 443 |
| 8 | 2019 | 2 | |
| 9 | Understanding the tumor immune microenvironment (TIME) for effective therapybreakdown → | 2018 | 3986 |
| 10 | 2017 | 145 | |
| 11 | Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanomabreakdown → | 2016 | 729 |
| 12 | 2015 | 0 | |
| 13 | 2014 | 114 | |
| 14 | Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunitybreakdown → | 2014 | 889 |
| 15 | 2014 | 218 | |
| 16 | FOXO3A directs a protective autophagy program in haematopoietic stem cellsbreakdown → | 2013 | 473 |
| 17 | Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Nichebreakdown → | 2013 | 452 |
| 18 | 2011 | 260 | |
| 19 | 2010 | 66 | |
| 20 | 2008 | 106 |
About Mikhail Binnewies
Mikhail Binnewies is a scholar working on Immunology, Hematology and Oncology, having authored 20 papers that have together received 8.1k indexed citations. Recurring topics across this work include Immune cells in cancer (10 papers), Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Inflammation biomarkers and pathways (4 papers), Acute Myeloid Leukemia Research (3 papers), CAR-T cell therapy research (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (4.5k citations), Oncology (3.9k citations) and Hematology (908 citations). Mikhail Binnewies has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Matthew F. Krummel, Edward W. Roberts, Kelly Kersten, Vincent Chan, Dmitry I. Gabrilovich, Weiping Zou, Suzanne Ostrand‐Rosenberg, Lisa M. Coussens, Catherine C. Hedrick and T. Kevin Howcroft. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.